Addressing this mechanism, innovative approaches like macrophage membrane-coated nanoparticles loaded with SD-208 (Mφ-SDNP), a TGF-βR1 kinase inhibitor, aim to directly inhibit the TGF-β signaling pathway, thereby preventing the initiation of EMT in cancer cells. The gene discussed is TGFB1; the disease is cancer.